Summary
E-pharma is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €497,097 and a net result of €108,372. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 18% of 6,651 sector peers (NACE 64, financial year 2025). The company has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
28-07
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial
Back to profitnet €108,372
Net result €108,372 after 2 loss-making years.
31-12
Financial
Liquidity more than quadruplescurrent ratio 1.51
Current ratio from 0.37 to 1.51; short-term debt falls from €1.8m to €548,811.
30-09
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format · 61 days late
2024
31-12
Financial
Weakest financial yearnet -€133,408
Net result drops to -€133,408, the lowest in the series; recovery starts the following year.
30-08
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format · 30 days late
09-07
Gazette deed
Resignation: Erik VAN NUFFEL (director)Appointment: AMBIXX BV (director) · Permanent representative: Marleen Slaets3 facts ▸
Gazette deed
Resignation: Erik VAN NUFFEL (director)
Appointment: AMBIXX BV (director) · Permanent representative: Marleen Slaets3 facts ▸
- Director resignation, Erik VAN NUFFEL (director)
- Director appointment, AMBIXX BV (director)
- Permanent representative, Marleen Slaets
2023
27-07
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format
2022
31-12
Financial
Back to profitnet €52,625
Net result €52,625 after one loss-making year.
28-07
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
2021
23-08
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format · 23 days late
2020
31-12
Financial
Highest result from 2018 to 2025net €673,801 ▲773%
Operating result €225,722, net result €673,801, both a record.
Show earlier events
31-12
Financial
Liquidity more than 12 timescurrent ratio 1.39
Current ratio from 0.11 to 1.39; short-term debt falls from €855,562 to €464,018.
31-12
Financial
Equity above €1mequity €1.0m ▲187%
A profit in every financial year since 2018 builds equity to €1.0m.
26-08
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format · 26 days late
2019
26-07
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format
2018
30-07
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format
2017
28-07
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 16 annual accounts filed, the latest 10 are here; all 16 are under Financials.
1 of 6 deeds read
About the unread acts
Of the 6 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 5 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.